DEPARTMENT OF LICENSING AND REGULATORY AFFAIRS  
DIRECTOR'S OFFICE  
MEDICINE - GENERAL RULES  
(By authority conferred on the director of the department of licensing and regulatory affairs  
by sections 16145, 16148, 16174, 16204, 16215, 16287, 17031, 17033, 17048, and 17076  
of the public health code, 1978 PA 368, MCL 333.16145, 333.16148, 333.16174,  
333.16204, 333.16215, 333.16287, 333.17031, 333.17033, 333.17048, and 333.17076, and  
Executive Reorganization Order Nos. 1991-9, 1996-2, 2003-1, and 2011-4, MCL  
338.3501, 445.2001, 445.2011, and 445.2030)  
PART 1. GENERAL PROVISIONS  
R 338.2401 Definitions.  
Rule 101. (1) As used in these rules:  
(a) “Board” means the Michigan board of medicine created under section 17021 of the  
code, MCL 333.17021.  
(b) “CK” means clinical knowledge.  
(c) “Code” means the public health code, 1978 PA 368, MCL 333.1101 to 333.25211.  
(d) “Department” means the department of licensing and regulatory affairs.  
(e) “ECFMG” means the Educational Commission for Foreign Medical Graduates.  
(f) “FSMB” means the Federation of State Medical Boards.  
(g) “USMLE” means the United States Medical Licensing Examination.  
(2) A term defined in the code has the same meaning when used in these rules.  
History: 2016 AACS; 2021 AACS; 2023 AACS.  
R 338.2403 Rescinded.  
History: 2016 AACS; 2021 AACS.  
R 338.2405 Rescinded.  
History: 2016 AACS; 2021 AACS.  
R 338.2407 Telehealth.  
Rule 107. (1) A licensee shall obtain consent for treatment before providing a telehealth  
service under section 16284 of the code, MCL 333.16284.  
Page 1  
(2) A licensee shall maintain proof of consent for telehealth treatment in the patient’s up-  
to-date medical record and satisfy section 16213 of the code, MCL 333.16213.  
(3) A licensee providing a telehealth service may prescribe a drug if the licensee is a  
prescriber acting within the scope of the licensee’s practice and in compliance with section  
16285 of the code, MCL 333.16285, and if the licensee does both of the following:  
(a) Refers the patient to a provider who is geographically accessible to the patient, if  
medically necessary.  
(b) Makes the licensee available to provide follow-up care services to the patient, or to  
refer the patient to another provider, for follow-up care.  
(4) A licensee providing any telehealth service shall do both of the following:  
(a) Act within the scope of the licensee’s practice.  
(b) Exercise the same standard of care applicable to a traditional, in-person healthcare  
service.  
History: 2021 AACS; 2023 AACS; 2024 AACS.  
R 338.2409 Prescribing of drugs by physician’s assistants; procedures and protocols.  
Rule 109. (1) Under sections 17048(2) and 17076(2) of the code, MCL 333.17048 and  
333.17076, and under the terms of a practice agreement, a physician’s assistant may  
prescribe a drug, including a controlled substance that is included in schedules 2 to 5 of  
part 72 of the code, MCL 333.7201 to 333.7231, subject to both of the following  
requirements:  
(a) If a physician's assistant prescribes a drug, the physician's assistant's name must be  
used, recorded, or otherwise indicated in connection with that prescription.  
(b) If a physician's assistant prescribes a drug that is included in schedules 2 to 5, the  
physician's assistant's Drug Enforcement Agency (DEA) registration number must be used,  
recorded, or otherwise indicated in connection with that prescription.  
(2) Under sections 17048(2) and 17076(3) of the code, MCL 333.17048 and 333.17076,  
and under the terms of a practice agreement, a physician's assistant may order, receive, and  
dispense complimentary starter dose drugs, including controlled substances that are  
included in schedules 2 to 5 of part 72 of the code, MCL 333.7201 to 333.7231, subject to  
both of the following requirements:  
(a) If a physician's assistant orders, receives, or dispenses a complimentary starter dose  
drug, the physician's assistant's name must be used, recorded, or otherwise indicated in  
connection with that order, receipt, or dispensing.  
(b) If a physician's assistant orders, receives, or dispenses a complimentary starter dose  
drug that is included in schedules 2 to 5, the physician's assistant's DEA registration  
number must be used, recorded, or otherwise indicated in connection with that order,  
receipt, or dispensing.  
History: 2016 AACS; 2021 AACS.  
R 338.2411 Delegation of prescribing controlled substances to an advanced practice  
registered nurse; limitation.  
Page 2  
Rule 111. (1) A physician may delegate the prescription of controlled substances listed  
in schedules 2 to 5 of part 72 of the code, MCL 333.7201 to 333.7231, to a registered nurse  
who holds specialty certification under section 17210 of the code, MCL 333.17210, except  
for a nurse anesthetist, if the delegating physician establishes a written authorization that  
has all the following information:  
(a) The name, license number, and signature of the delegating physician.  
(b) The name, license number, and signature of the nurse practitioner, nurse midwife, or  
clinical nurse specialist.  
(c) The limitations or exceptions to the delegation.  
(d) The effective date of the delegation.  
(2) The delegating physician shall review and update a written authorization on an annual  
basis after the original date or the date of amendment, if amended. The delegating  
physician shall note the review date on the written authorization.  
(3) The delegating physician shall maintain a written authorization at the delegating  
physician’s primary place of practice.  
(4) The delegating physician shall provide a copy of the signed, written authorization to  
the nurse practitioner, nurse midwife, or clinical nurse specialist.  
(5) The delegating physician shall ensure that an amendment to the written authorization  
satisfies subrules (1) to (4) of this rule.  
(6) A delegating physician may authorize a nurse practitioner, a nurse midwife, or a  
clinical nurse specialist to issue multiple prescriptions allowing the patient to receive a total  
of up to a 90-day supply of a schedule 2 controlled substance.  
History: 2016 AACS; 2021 AACS; 2023 AACS; 2024 AACS.  
R 338.2413 Training standards for identifying victims of human trafficking;  
requirements.  
Rule 113. (1) Under section 16148 of the code, MCL 333.16148, an individual seeking  
licensure or who is licensed shall have completed training in identifying victims of human  
trafficking that satisfies the following standards:  
(a) Training content must cover all the following:  
(a) Understanding the types and venues of human trafficking in this state or the United  
States.  
(ii) Identifying victims of human trafficking in healthcare settings.  
(iii) Identifying the warning signs of human trafficking in healthcare settings for adults  
and minors.  
(iv) Identifying resources for reporting the suspected victims of human trafficking.  
(b) Acceptable providers or methods of training include any of the following:  
(it) Training offered by a nationally recognized or state-recognized, health-related  
organization.  
(ii) Training offered by, or in conjunction with, a state or federal agency.  
(iii) Training obtained in an educational program that has been approved for initial  
licensure, or by a college or university.  
(iv) Reading an article related to the identification of victims of human trafficking that  
satisfies the requirements of subdivision (a) of this subrule and is published in a peer-  
reviewed journal, healthcare journal, or professional or scientific journal.  
Page 3  
(c) Acceptable modalities of training include any of the following:  
(i) Teleconference or webinar.  
(ii) Online presentation.  
(iii) Live presentation.  
(iv) Printed or electronic media.  
(2) The department may select and audit an individual and request documentation of proof  
of completion of training. If audited by the department, the individual shall provide an  
acceptable proof of completion of training, including either of the following:  
(a) Proof of completion certificate issued by the training provider that includes the date,  
provider name, name of training, and individual’s name.  
(b) A self-certification statement by the individual. The certification statement must  
include the individual’s name and either of the following:  
(i) For training completed under subrule (1)(b)(i) to (iii) of this rule, the date, training  
provider name, and name of training.  
(ii) For training completed under subrule (1)(b)(iv) of this rule, the title of the article,  
author, publication name of the peer-reviewed journal, healthcare journal, or professional  
or scientific journal, and the date, volume, and issue of publication, as applicable.  
History: 2016 AACS; 2021 AACS; 2023 AACS; 2024 AACS.  
PART 2. LICENSES  
R 338.2421 Accreditation standards for approval of medical schools and  
postgraduate training programs; adoption by reference.  
Rule 121. (1) The standards for accrediting medical schools developed and adopted by  
the Liaison Committee on Medical Education, 655 K Street NW, Suite 100, Washington,  
District of Columbia 20001-2399, set forth in the publication titled “Functions and  
Structure of a Medical School,” effective July 1, 2025, which are available at no cost on  
medical school accredited by the Liaison Committee on Medical Education is approved.  
(2) The standards for accrediting medical schools developed and adopted by the  
Committee on Accreditation of Canadian Medical Schools, 10th FLR – 150 Elgin Street,  
Ottawa, ON K2P 1L4, set forth in the publication titled “CACMS Standards and  
Elements,” effective July 1, 2022, which are available at no cost on the committee’s  
school accredited by the Committee on Accreditation of Canadian Medical Schools is  
approved.  
(3) The standards for approval of a postgraduate training program developed and adopted  
by the Accreditation Council for Graduate Medical Education, 401 North Michigan  
Avenue, Suite 2000, Chicago, Illinois 60611, set forth in the publication titled “ACGME  
Common Program Requirements,” effective July 1, 2023, which are available at no cost on  
A medical postgraduate training program accredited by the Accreditation Council for  
Graduate Medical Education is approved.  
Page 4  
(4) The standards for approval of a resident training program by the College of Family  
Physicians of Canada, 2630 Skymark Avenue, Mississauga, Ontario, Canada L4W 5A4,  
set forth in the publication titled “Standards of Accreditation for Residency Programs in  
Family Medicine,” July 2020 version, which are available at no cost on the college’s  
residency program accredited by the College of Family Physicians of Canada is approved.  
(5) The standards for approval of a resident training program by the Royal College of  
Physicians and Surgeons of Canada, 774 Echo Drive, Ottawa, Ontario, Canada K1S 5N8,  
set forth in the publication titled “General Standards of Accreditation for Residency  
Programs,” July 2020 edition, which are available at no cost on the college’s website at  
accredited by the Royal College of Physicians and Surgeons is approved.  
(6) Copies of the standards adopted by reference in subrules (1) to (5) of this rule are  
available for inspection and distribution at a cost of 25 cents per page from the Board of  
Medicine, Bureau of Professional Licensing, Department of Licensing and Regulatory  
Affairs, 611 West Ottawa, P.O. Box 30670, Lansing, Michigan 48909.  
History: 2016 AACS; 2021 AACS; 2023 AACS; 2024 AACS; 2026 MR 6, Eff. March 19, 2026.  
R 338.2423 Doctor of medicine; license requirements; United States and Canadian  
graduates.  
Rule 123. An applicant for a doctor of medicine license who graduated from a medical  
school inside the United States or Canada shall satisfy the requirements of the code, the  
rules promulgated under the code, and all the following requirements:  
(a) Provide the required fee and a completed application on a form provided by the  
department.  
(b) Provide proof, as directed by the department, verifying completion of a degree from a  
medical school that satisfies the standards under R 338.2421(1) or (2).  
(c) Provide proof, as directed by the department, verifying passing scores on all steps of  
the USMLE adopted under R 338.2431 and verifying satisfaction of all the requirements  
under R 338.2431.  
(d) Provide proof, as directed by the department, verifying completion of a minimum of  
1 year of postgraduate clinical training in a program that satisfies the requirements under  
R 338.2421(3), (4), or (5).  
(e) Provide a certificate of completion of the postgraduate training required under  
subdivision (d) of this rule to the department no more than 15 days before the scheduled  
date of completion.  
History: 2016 AACS; 2021 AACS; 2023 AACS; 2024 AACS; 2026 MR 6, Eff. March 19, 2026.  
R 338.2425 Doctor of medicine; license requirements; foreign graduates.  
Rule 125. An applicant for a doctor of medicine license who graduated from a medical  
school outside the United States or Canada shall satisfy the requirements of the code, the  
rules promulgated under the code, and all the following requirements:  
Page 5  
(a) Provide the required fee and a completed application on a form provided by the  
department.  
(b) Provide proof, as directed by the department, verifying certification from the ECFMG  
that the applicant has graduated from a medical school listed in the World Directory of  
Medical Schools.  
(c) Provide proof, as directed by the department, verifying passing scores on all steps of  
the USMLE adopted under R 338.2431 and verifying satisfaction of all the requirements  
under R 338.2431.  
(d) Provide proof, as directed by the department, verifying completion of a minimum of  
1 year of postgraduate clinical training in a program that satisfies the requirements under  
R 338.2421(3), (4), or (5).  
(e) Provide a certificate of completion of the postgraduate training required under  
subdivision (d) of this rule to the department no more than 15 days before the scheduled  
date of completion.  
History: 2016 AACS; 2021 AACS; 2023 AACS; 2024 AACS; 2026 MR 6, Eff. March 19, 2026.  
R 338.2427 Licensure by endorsement.  
Rule 127. (1) An applicant for a doctor of medicine license by endorsement shall satisfy  
the requirements of the code, the rules promulgated under the code, and all the following  
requirements:  
(a) Provide the required fee and a completed application on a form provided by the  
department.  
(b) Provide proof, as directed by the department, verifying a current and full doctor of  
medicine license in another state or province of Canada.  
(c) If the applicant is licensed as a doctor of medicine in a province in Canada, provide  
proof, as directed by the department, verifying that the applicant completed the educational  
requirements in Canada or in the United States for licensure as a doctor of medicine in  
Canada or in the United States.  
(d) Provide proof, as directed by the department, verifying passing scores on either of the  
following examinations for a doctor of medicine license in another state or province of  
Canada to obtain licensure as a doctor of medicine in another state or in a province of  
Canada:  
(i) All steps of the USMLE adopted under R 338.2431 and provide proof verifying  
satisfaction of all the requirements under R 338.2431.  
(ii) Part I of the Medical Council of Canada Qualifying Examination.  
(e) Provide proof, as directed by the department, verifying completion of a minimum of  
1 year of postgraduate clinical training in a program that satisfies the requirements under  
R 338.2421(3), (4), or (5).  
(2) An applicant who provides proof, as directed by the department, verifying a current  
and full license in good standing as a doctor of medicine in another state or a province of  
Canada for not less than 10 years before the date of filing the application for a doctor of  
medicine license by endorsement is presumed to satisfy the requirements of subrule (1)(c),  
(d), and (e) of this rule.  
(3) An applicant who is or has been licensed, registered, or certified in a health profession  
or specialty by another state, the United States military, the federal government, or another  
Page 6  
country shall disclose that fact on the application form. The applicant shall satisfy the  
requirements of section 16174(2) of the code, MCL 333.16174, including verification from  
the issuing entity showing that disciplinary proceedings are not pending against the  
applicant and, except as otherwise provided under section 17011(4) of the code, MCL  
333.17011, sanctions are not in force when the application is submitted. If licensure is  
granted and it is determined that sanctions have been imposed, the disciplinary  
subcommittee may impose appropriate sanctions under section 16174(5) of the code, MCL  
333.16174.  
History: 2016 AACS; 2021 AACS; 2023 AACS; 2024 AACS; 2026 MR 6, Eff. March 19, 2026.  
R 338.2429 Educational limited license.  
Rule 129. (1) An individual not eligible for a doctor of medicine license shall obtain an  
educational limited license before engaging in postgraduate training.  
(2) An applicant for an educational limited license who is from a medical school inside  
the United States or Canada shall satisfy the requirements of the code, the rules  
promulgated under the code, and all the following requirements:  
(a) Provide the required fee and a completed application on a form provided by the  
department.  
(b) Provide proof, as directed by the department, verifying that the applicant has  
graduated or is expected to graduate within 3 months after the date of the application from  
a medical school that satisfies the requirements under R 338.2421(1) or (2).  
(c) Provide proof, as directed by the department, verifying that the applicant has been  
accepted into a postgraduate training program that satisfies the requirements under R  
338.2421(3).  
(3) An applicant for an educational limited license who is from a medical school outside  
the United States or Canada shall satisfy the requirements of the code, the rules  
promulgated under the code, and all the following requirements:  
(a) Provide the required fee and a completed application on a form provided by the  
department.  
(b) Provide proof, as directed by the department, verifying certification from the ECFMG  
and that the applicant has satisfied both of the following requirements:  
(i) Graduated from a medical school listed in the World Directory of Medical Schools.  
(ii) Received passing scores on step 1 and step 2 CK of the USMLE adopted under R  
338.2431.  
(c) Provide proof, as directed by the department, verifying that the applicant has been  
accepted into a postgraduate training program that satisfies the requirements under R  
338.2421(3).  
(4) Under section 17012(2) of the code, MCL 333.17012, an educational limited license  
is renewable for not more than 5 years. Relicensure of the educational limited license is  
considered the same as renewal for the purposes of this subrule.  
History: 2016 AACS; 2021 AACS; 2023 AACS; 2024 AACS; 2026 MR 6, Eff. March 19, 2026.  
R 338.2431 Examination; adoption; passing scores; limitation on attempts.  
Page 7  
Rule 131. (1) The USMLE, developed and administered by the FSMB, is approved and  
adopted, which consists of the following steps:  
(a) USMLE Step 1.  
(b) USMLE Step 2 CK.  
(c) USMLE Step 3.  
(2) The passing score for each step of the USMLE accepted for licensure is the passing  
score established by the FSMB.  
(3) An applicant shall not make more than 4 attempts to pass any step of the USMLE.  
History: 2016 AACS; 2021 AACS; 2023 AACS; 2024 AACS.  
R 338.2433 Rescinded.  
History: 2016 AACS; 2021 AACS.  
R 338.2435 Clinical academic limited license.  
Rule 135. An applicant for a clinical academic limited license shall satisfy the  
requirements of the code, the rules promulgated under the code, and all the following  
requirements:  
(a) Provide the required fee and a completed application on a form provided by the  
department.  
(b) Provide proof, as directed by the department, verifying that the applicant has been  
appointed to a position in an academic institution.  
(c) Provide proof, as directed by the department, verifying 1 of the following:  
(i) The applicant has graduated from a medical school that satisfies the requirements  
under R 338.2421(1) or (2).  
(ii) Certification from the ECFMG that the applicant has satisfied both of the following  
requirements:  
(A) Graduated from a medical school listed in the World Directory of Medical Schools.  
(B) Received passing scores on step 1 and step 2 CK of the USMLE adopted under R  
338.2431.  
History: 2016 AACS; 2021 AACS; 2023 AACS; 2026 MR 6, Eff. March 19, 2026.  
R 338.2437 Relicensure.  
Rule 137. (1) An applicant whose doctor of medicine license has lapsed for less than 3  
years preceding the date of application for relicensure may be relicensed under section  
16201(3) of the code, MCL 333.16201, if the applicant satisfies the requirements of the  
code, the rules promulgated under the code, and all the following requirements:  
(a) Provides the required fee and a completed application on a form provided by the  
department.  
(b) Provides proof, as directed by the department, verifying the completion of not less  
than 150 hours of continuing education that satisfies the requirements of R 338.2443 during  
the 3 years immediately preceding the date of the application for relicensure.  
Page 8  
(c) Establishes good moral character, as that term is defined in, and determined under,  
1974 PA 381, MCL 338.41 to 338.47.  
(d) An applicant who holds or has ever held a license to practice medicine shall establish  
all the following requirements:  
(i) Disciplinary proceedings are not pending against the applicant.  
(ii) If sanctions have been imposed against the applicant, the sanctions are not in force  
when the application is submitted.  
(iii) A previously held license was not surrendered or allowed to lapse to avoid  
discipline.  
(2) An applicant whose doctor of medicine license has been lapsed for 3 years but less  
than 5 years may be relicensed under section 16201(4) of the code, MCL 333.16201, if the  
applicant provides fingerprints as set forth in section 16174(3) of the code, MCL  
333.16174, and satisfies the requirements of subrule (1) of this rule and either of the  
following requirements:  
(a) Provides proof, as directed by the department, verifying that the applicant is currently  
licensed and in good standing as a doctor of medicine in another state or a province of  
Canada.  
(b) Provides proof, as directed by the department, verifying completion of 1 of the  
following during the 3 years immediately preceding the date of the application for  
relicensure:  
(i) Successfully passed the Special Purpose Examination (SPEX) offered by the FSMB.  
The passing score is the passing score established by the FSMB.  
(ii) Successfully completed a postgraduate training program that satisfies the  
requirements under R 338.2421(3), (4), or (5).  
(iii) Successfully completed a physician re-entry program that is an organizational  
member of the Coalition for Physician Enhancement (CPE) or a physician re-entry program  
affiliated with a medical school that satisfies the requirements under R 338.2421(1) or (2).  
Proof of successful completion includes a certificate or letter of completion from the  
physician re-entry program that says that the applicant is competent and safe to practice,  
with no limitations or restrictions.  
(3) An applicant whose doctor of medicine license has lapsed for 5 years or more may be  
relicensed under section 16201(4) of the code, MCL 333.16201, if the applicant provides  
fingerprints as set forth in section 16174(3) of the code, MCL 333.16174, and satisfies the  
requirements of subrule (1) of this rule and either of the following requirements:  
(a) Provides proof, as directed by the department, verifying that the applicant is currently  
licensed and in good standing as a doctor of medicine in another state or a province of  
Canada.  
(b) Provides proof, as directed by the department, verifying completion of both of the  
following during the 3 years immediately preceding the date of the application for  
relicensure:  
(i) Successfully passed the SPEX offered by the FSMB. The passing score is the passing  
score established by the FSMB.  
(ii) Successfully completed 1 of the following training options:  
(A) A postgraduate training program that satisfies the requirements under R  
338.2421(3), (4), or (5).  
Page 9  
(B) A physician re-entry program that is an organizational member of the CPE or a  
physician re-entry program affiliated with a medical school that satisfies the requirements  
under R 338.2421(1) or (2). Proof of successful completion includes a certificate or letter  
of completion from the physician re-entry program that says that the applicant is competent  
and safe to practice, with no limitations or restrictions.  
(4) If required to complete the requirements of subrule (2)(b)(ii) or (iii) or (3)(b)(ii)(A) or  
(B) of this rule, the applicant may obtain an educational limited license for the sole purpose  
of completing that training.  
(5) An applicant with an educational limited license may be relicensed under section  
16201(3) or (4) of the code, MCL 333.16201, if the applicant satisfies subrule (1) of this  
rule and the requirements under R 338.2429.  
(6) An applicant who is or has been licensed, registered, or certified in a health profession  
or specialty by another state, the United States military, the federal government, or another  
country shall disclose that fact on the application form. The applicant shall satisfy the  
requirements of section 16174(2) of the code, MCL 333.16174, including verification from  
the issuing entity showing that disciplinary proceedings are not pending against the  
applicant and sanctions are not in force when the application is submitted. If licensure is  
granted and it is determined that sanctions have been imposed, the disciplinary  
subcommittee may impose appropriate sanctions under section 16174(5) of the code, MCL  
333.16174.  
History: 2016 AACS; 2021 AACS; 2023 AACS; 2024 AACS; 2026 MR 6, Eff. March 19, 2026.  
PART 3. CONTINUING EDUCATION  
R 338.2441 License renewals.  
Rule 141. (1) An applicant for renewal shall satisfy the requirements of the code and the  
rules promulgated under the code.  
(2) An applicant for license renewal who has been licensed in the 3-year period  
immediately preceding the application for renewal shall accumulate a minimum of 150  
hours of continuing education in activities approved under R 338.2443 during the 3 years  
immediately preceding the application for renewal.  
(3) Submission of an application for renewal constitutes the applicant’s certification of  
compliance with the requirements of this rule. The licensee shall maintain documentation  
of satisfying the requirements of this rule for 4 years after the date of applying for license  
renewal. Failure to satisfy this rule is a violation of section 16221(h) of the code, MCL  
333.16221.  
(4) The department may select and audit a sample of licensees who have renewed their  
license and request proof of compliance with subrule (2) of this rule. If audited, the licensee  
shall provide documentation as specified in R 338.2443.  
(5) An applicant must submit a request for a waiver of continuing education requirements  
to the department for the board’s consideration not less than 30 days before the last  
regularly scheduled board meeting before the expiration date of the license.  
History: 2016 AACS; 2021 AACS; 2023 AACS; 2024 AACS.  
Page 10  
R 338.2443 Acceptable continuing education; requirements; limitations.  
Rule 143. (1) The 150 hours of continuing education required under R 338.2441 must  
satisfy the following requirements, as applicable:  
(a) Credit for a continuing education program or activity that is identical or substantially  
equivalent to a program or activity for which the licensee has already earned credit during  
the renewal period cannot be granted.  
(b) A minimum of 1 hour of continuing education must be earned in medical ethics.  
(c) A minimum of 3 hours of continuing education must be earned in pain and symptom  
management under section 17033(2) of the code, MCL 333.17033. At least 1 of the 3 hours  
must include controlled substances prescribing. Continuing education hours in pain and  
symptom management may include, but are not limited to, any of the following areas:  
(i) Public health burden of pain.  
(ii) Ethics and health policy related to pain.  
(iii) Michigan pain and controlled substance laws.  
(iv) Pain definitions.  
(v) Basic sciences related to pain including pharmacology.  
(vi) Clinical sciences related to pain.  
(vii) Specific pain conditions.  
(viii) Clinical physician communication related to pain.  
(ix) Management of pain, including evaluation and treatment and non-pharmacological  
and pharmacological management.  
(x) Ensuring quality pain care and controlled substances prescribing.  
(xi) Michigan programs and resources relevant to pain.  
(d) A minimum of 75 continuing education credits must be obtained through category 1  
programs listed in subrule (2) of this rule.  
(e) Completion of implicit bias training under R 338.7004 during the 3 years immediately  
preceding the application for renewal may be used toward satisfaction of the requirements  
of R 338.2441(2) and subrule (1) of this rule.  
(2) The following activities are acceptable category 1 continuing education:  
Activity and Proof of Completion  
Number of Continuing Education Hours  
granted/allowed for the activity  
(a) Attendance at or participation in a The number of continuing education  
continuing education program or hours for a specific program or activity is  
activity related to the practice of the number of hours approved by the  
medicine, including, but not limited to, sponsor or the approving organization for  
live, in-person programs, interactive or the specific program. A maximum of  
monitored teleconference, audio- 150 continuing education hours may be  
conference, or web-based programs, earned for this activity during the  
online programs, and journal articles renewal period.  
with a self-study component or other  
self-study programs approved or  
offered by any of the following  
organizations:  
Page 11  
- Accreditation Council for Continuing  
Medical Education (ACCME)  
including non-ACCME accredited  
providers engaging in joint  
providership with ACCME accredited  
providers.  
- American Academy of Family  
Physicians.  
- American Medical Association.  
- American Osteopathic Association.  
- Michigan Osteopathic Association.  
- Michigan State Medical Society.  
If audited, the licensee shall provide a  
copy of the letter or certificate of  
completion showing the licensee’s  
name, number of continuing education  
hours earned, sponsor name or the  
name of the organization that approved  
the program or activity for continuing  
education credit, and the date the  
program was held or the activity  
completed.  
(b) Taking and passing a specialty board Fifty continuing education hours are  
certification  
or  
recertification granted for successfully passing a  
board certification or  
examination for a specialty board specialty  
recognized by the American Board of recertification examination during the  
Medical Specialties, the American renewal period. A maximum of 50  
Board of Physician Specialties, or the continuing education hours may be  
National Board of Physicians and earned for this activity in each renewal  
Surgeons.  
period.  
If audited, the licensee shall provide  
proof from the specialty board of the  
successful passing of the examination.  
(c) Successfully completing an activity One continuing education hour is granted  
that is required for maintenance of a for every 60 minutes spent on the  
specialty certification for a board activity. A maximum of 30 continuing  
recognized by the American Board of education hours may be earned for this  
Medical Specialties, the American activity in each renewal period.  
Board of Physician Specialties, or the  
National Board of Physicians and  
Surgeons that does not satisfy the  
requirements of subdivision (a) or (b)  
of this subrule.  
Page 12  
If audited, the licensee shall provide  
proof from the specialty board that the  
activity was required for maintenance  
of certification, that the activity was  
successfully completed, and the date of  
completion.  
(d) Participation in a clinical training Fifty continuing education hours per year  
program that satisfies any of the may be granted for this activity.  
A
requirements of R 338.2421(3), (4), or maximum of 150 continuing education  
(5) or is accredited by a board hours may be earned per renewal period.  
recognized by the American Board of  
Medical Specialties, the American  
Board of Physician Specialties, or the  
National Board of Physicians and  
Surgeons.  
To receive credit, the  
licensee shall be enrolled for a  
minimum of 5 months in a 12-month  
period.  
If audited, the licensee shall provide a  
letter from the program director  
verifying the licensee took part in the  
program.  
(3) The following activities are acceptable category 2 continuing education:  
Activity and Proof of Completion  
Number of Continuing Education Hours  
granted/allowed for the activity  
(a) Serving as a clinical instructor for Two continuing education hours are  
medical students or residents engaged granted for each 50 to 60 minutes of  
in a postgraduate training program that scheduled instruction. Additional credit  
satisfies  
338.2421(3), (4), or (5).  
requirements  
of  
R for preparation of a lecture cannot be  
granted. A maximum of 48 continuing  
education hours may be earned for this  
To receive credit, the clinical activity in each renewal period.  
instructorship must not be the  
licensee’s  
primary  
employment  
function.  
If audited, the licensee shall provide  
proof of scheduled instructional hours  
and a letter from the program director  
verifying the licensee’s role.  
(b) Initial presentation of a scientific Two continuing education hours are  
exhibit, poster, or paper to a granted for each presentation.  
professional medical organization. additional credit is granted for  
preparation of the presentation.  
maximum of 24 continuing education  
No  
A
Page 13  
If audited, the licensee shall provide a hours may be earned for this activity in  
copy of the document presented with each renewal period. Under subrule  
proof of presentation or a letter from (1)(a) of this rule, credit for a  
the program sponsor verifying the date presentation is granted only once per  
of the presentation.  
renewal period.  
(c) Publication of a scientific article Six continuing education hours are  
relating to the practice of medicine in a granted for serving as the primary author.  
peer-reviewed journal or periodical.  
Three continuing education hours are  
granted for serving as a secondary  
If audited, the licensee shall provide a author. A maximum of 24 continuing  
copy of the publication that identifies education hours may be earned for this  
the licensee as the author or a activity in each renewal period. Under  
publication acceptance letter and subrule (1)(a) of this rule, credit for an  
documentation of the peer-review article is granted once per renewal  
process.  
period.  
(d) Initial publication of a chapter or a part Five continuing education hours are  
of a chapter related to the practice of granted for serving as the primary author.  
medicine in either of the following Two continuing education hours are  
textbooks:  
granted for serving as a secondary  
author. A maximum of 24 continuing  
education hours may be earned for this  
activity in each renewal period. Under  
subrule (1)(a) of this rule, credit for  
- A professional healthcare textbook.  
- A peer-reviewed textbook.  
If audited, the licensee shall provide a publication is granted once per renewal  
copy of the publication that identifies period.  
the licensee as the author or a  
publication acceptance letter.  
(e) Participating on any of the following Eighteen continuing education hours are  
committees:  
granted for taking part on a committee.  
A maximum of 18 continuing education  
- A peer-review committee dealing hours may be earned for this activity in  
with quality of patient care as it relates each renewal period.  
to the practice of medicine.  
- A committee dealing with utilization  
review as it relates to the practice of  
medicine.  
- A healthcare organization committee  
dealing with patient care issues related  
to the practice of medicine.  
- A national or state committee, board,  
council, or association related to the  
practice of medicine.  
Participation in a committee, board,  
council, or association is considered  
acceptable if it enhances the  
Page 14  
participant’s  
knowledge  
and  
understanding of the field of medicine.  
If audited, the licensee shall provide a  
letter from an organization official  
verifying the licensee’s participation in  
not less than 50% of the regularly  
scheduled meetings of the committee,  
board, council, or association.  
History: 2016 AACS; 2021 AACS; 2023 AACS; 2024 AACS; 2026 MR 6, Eff. March 19, 2026.  
Page 15  
;